Immune cell phenotype and functional defects in Netherton syndrome

Area of Science:

• Immunology
• Genetics
• Dermatology

Background:

• Netherton syndrome (NS) is a rare, life-threatening genetic disorder caused by SPINK5 mutations.
• It leads to a compromised skin barrier and severe atopic diathesis, increasing susceptibility to bacterial infections.
• The precise immune deficiency underlying NS remains incompletely understood.

Purpose of the Study:

• To investigate lymphocyte phenotypes and function in Netherton syndrome patients.
• To correlate immune cell aberrations with clinical infection frequency.
• To assess the impact of intravenous immunoglobulin therapy (IVIG) on immune profiles and clinical outcomes.

Main Methods:

• Analysis of blood lymphocyte subpopulations (B cells, T cells, NK cells) using flow cytometry in 11 Finnish NS patients (aged 3-17 years) and healthy controls.
• Comparison of immune cell profiles between NS patients and age-matched atopic dermatitis (AD) patients.
• Correlation analysis between lymphocyte phenotypes and infection frequency.
• Evaluation of IVIG therapy effects in three NS patients.

Main Results:

• NS patients displayed significantly altered B cell populations, including increased naive B cells and decreased memory B cells crucial for pathogen response.
• Reduced naive CD4+ T cells and elevated CD8+ T central memory cells were observed, alongside impaired NK cell cytotoxicity.
• Distinctive T and NK cell phenotypes in NS differed from those in AD patients.
• Skin infection frequency correlated with specific T and B cell proportions.
• IVIG therapy increased naive T cells and effector memory CD8+ cells, while decreasing activated B cells and plasmablasts.

Conclusions:

• Netherton syndrome is characterized by novel quantitative and functional lymphocyte aberrations.
• These immune dysbalances correlate with the increased susceptibility to infections observed in NS.
• IVIG therapy demonstrated clinical benefit by partially normalizing these immune abnormalities.